BioSpace
U.S. industry-aligned, pro-science, minimal political bias
Background
BioSpace was founded in 1985 by Jennifer King as a directory of biotech organizations during the early days of Silicon Valley. Over the following decades it evolved from a print-era directory into a digital platform combining industry news with one of the largest life sciences job boards in the United States. The company relocated its headquarters to the Des Moines, Iowa area and remains a small, privately held business. Early venture backing came from Sequoia Capital and Brentwood Associates, though no major acquisition by a larger media or staffing conglomerate has been publicly confirmed. Media Bias/Fact Check rates BioSpace as pro-science with mostly factual reporting, noting a pro-pharmaceutical industry tilt and a failed fact check in May 2022 that moved its rating from 'high' to 'mostly factual.' Its editorial team selects news topics independently of advertisers, though it also publishes clearly labeled sponsored and partnered content. In 2026, BioSpace won Azbee Awards and Neal Awards for editorial excellence in specialized business journalism. Coverage of the Trump second term has closely tracked FDA leadership turnover, drug pricing executive orders, tariff uncertainty, and deregulatory manufacturing initiatives — reporting both the industry disruption and the regulatory relief with an analytical rather than advocacy tone.
Sources
- About Us - BioSpace
- BioSpace - Bias and Credibility - Media Bias/Fact Check
- BioSpace Celebrates 30 Years as Leading Life Sciences News and Careers Platform
- BioSpace elevates journalism as biopharma evolves in the Trump era - BioSpace
- Here Today, Gone Tomorrow: Trump's Policies Give Biopharma Whiplash - BioSpace
- BioSpace 2026 Company Profile - Tracxn
- Editorial - BioSpace
Profile compiled 2026-08-05; refreshed when ownership, funding, or the administration changes.